Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEL100 transplant with lenalidomide + prednisone consolidation and lenalidomide maintenance in elderly newly diagnosed multiple myeloma
2005-004730-41Phase 2Completed
- Sponsor
- Fondazione EMN Italy
- Start
- Nov 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lenalidomide, melphalan and prednisone in multiple myeloma (MM), sponsored by Fondazione EMN Italy. Started Nov 2007; status: completed.
02
Drugs
lenalidomidemelphalanprednisone
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2005-004730-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004730-41.